Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

At-Home HPV test kits could boost cervical cancer screening in Hard-to-Reach women

NCT ID NCT04716127

Prevention Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether offering a vaginal self-sampling kit directly to women aged 50-65 who had not had a cervical smear in over three years would increase screening participation. Women received a kit to use at home and mail to a lab for HPV testing. The goal was to see how many accepted the kit and completed the test, with a focus on reaching underserved populations in southern France.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
vaginal self-sampling kit for HPV testing
What this could lead to
If successful, this approach could increase cervical cancer screening rates among women who currently avoid it, helping catch the disease earlier.
What could go wrong
This is a completed behavioral study, not a treatment trial. It tests a screening method, not a cure, and results may not apply to other regions or age groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

656 people

The number who actually took part.

Started

Sep 2021

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Asymptomatic women 50 to 65 years old (50 and 65 years included) * With no cervical smear (or gynecologic examination) or HPV test for at least 3 years (≥ 3 years) * Able to understand the study and provide voluntarily a written consent to participate * Able to understand and answer the questions of the study questionnaire by themselves or with the help of a self-chosen third party * Beneficiary of social security insurance Exclusion Criteria: * Women deprived of their liberty, protected adults or vulnerable persons * Known cervical lesion or known HPV status * History of hysterectomy * History of cervix pathology (conization, laser treatment of the cervix) * History of cervical cancer * Known immune-depression

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cervical cancer cervix disorder human papilloma virus infection Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical cancer Human papilloma virus Uterine cervical disease

Contacts and locations

Locations

  • Arnaud de Villeneuve Hospital, clinical trials Department

    Montpellier, Herault, 34295, France

  • Mammobile Hérault

    Montpellier, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.